glp 1 receptor agonists for type 2 diabetes GLP-1RAs Reduce External Eating Behavior with New GLP-1 Guidelines for Type

4 Clinical evidence in T2DM management A wide range of clinical trials and research have been performed to assess the effectiveness, safety, and tolerability of short-acting against long-acting GLP-1 analogues in the treatment and management of T2DM and obesity

Meanwhile, ongoing clinical research and rising demand for broad, comprehensive treatment options keep pushing adoption across different regions, year after year

doi:10.2174/1573403X1604201229115531 Stumvoll M, Goldstein BJ, van Haeften TW

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Eur J Intern Med

Only a minor part of the administered radioactivity was excreted as liraglutide-related metabolites in urine or feces (6% and 5%, respectively)